| Trial | Updated / Type |
Status | Phase | Were Results Reported |
Reported Actual Enrollment |
(MeSH) Terms |
Why Stopped
Limitations And Caveats |
Annotator decisions |
|---|---|---|---|---|---|---|---|---|
| NCT02415595 2013-005487-26 Details | 2018-09-19 Interventional | 2 | 210 | BMS-955176 Acquired Immuno… HIV Infections Infection, Huma… | The trial ended early due to GI intolerability and treatment-emergent resistance. - | |||
| NCT00413959 Details | 2018-09-19 Interventional | 2 | 12 | Bortezomib Cyclophosphamid… Dexamethasone Rituximab Lymphoma Lymphoma, B-Cel… Lymphoma, Non-H… | - - | |||
| NCT02495662 Details | 2018-09-18 Interventional | 2 | 30 | Methylprednisol… Methylprednisol… Methylprednisol… Prednisolone Prednisolone ac… Prednisolone he… Prednisolone ph… Fistula Neointima Vascular Remode… Hemodynamics Renal Dialysis | Slow inclusion - | |||
| NCT01992562 Details | 2018-09-18 Interventional | 4 | 0 | Ziconotide Bone Marrow Dis… Pain Spinal Cord Dis… Painful Myelopa… Painful Neuropa… | Logistical issues with study process and recruitment - | |||
| NCT03673605 Details | 2018-09-17 Interventional | 4 | 0 | Rivaroxaban Warfarin Atrial Fibrilla… Constriction, P… Mitral Valve St… | No patients Enrollment - | |||
| NCT03104998 Details | 2018-09-17 Interventional | 4 | 0 | Coenzyme Q10 Ubiquinone Infertility Idiopathic Infe… | No further patient enrollment - | |||
| NCT01691872 Details | 2018-09-17 Interventional | 1 | 0 | Ezogabine Epilepsies, Par… Epilepsy, Parti… | Development plan of retigabine XR in Japan was readjusted. - | |||
| NCT03504566 Details | 2018-09-14 Interventional | 4 | 0 | Empagliflozin Glucuronyl gluc… Linagliptin Telmisartan Albuminuria Diabetic Nephro… Diabetic Nephro… | Registered and published incorrectly - | |||
| NCT03347461 Details | 2018-09-14 Interventional | 4 | 0 | Ciprofloxacin Dexamethasone Otitis Media Otitis Media wi… Otitis Media Wi… Otorrhea | Low use of Otiprio among otolaryngologists. - | |||
| NCT02939846 Details | 2018-09-14 Interventional | 1 | 0 | Trametinib Cancer | Change in strategy - | |||
| NCT02447939 Details | 2018-09-14 Interventional | 1 | 0 | Dabrafenib Trametinib Melanoma | Change in strategy - | |||
| NCT01440595 2011-003299-36 Details | 2018-09-14 Interventional | 2 | 5 | Grazoprevir Peginterferon a… Ribavirin Hepatitis Hepatitis A Hepatitis C Hepatitis C, Ch… | Preliminary results of MK-5172 PN003 (NCT01353911) suggested a possible dose relationship to
elevated transaminase levels in treatment with grazoprevir. - | |||
| NCT03212807 Details | 2018-09-13 Interventional | 2 | 0 | Durvalumab Lenalidomide Lymphoma EBV Related Non… Primary CNS Lym… Primary Testicu… | FDA Hold for Combination Studies using Imids and PD1/PDL1 Compounds - | |||
| NCT02462525 2014-002609-39 Details | 2018-09-13 Interventional | 1 | 74 | Dexamethasone Pomalidomide Multiple Myelom… Neoplasms, Plas… | No Go decision for ABBV-838 - | |||
| NCT02058407 Details | 2018-09-13 Interventional | 1 | 33 | Pharmaceutical … Bronchiectasis | Drug related AEs observed upon repeat dosing that with longer treatment duration could become
worse. Required action on some biomarkers not observed. - | |||
| NCT01656395 2012-000643-27 Details | 2018-09-13 Interventional | 2 | 576 | Montelukast Asthma | - - | |||
| NCT02487953 Details | 2018-09-12 Interventional | 2 | 0 | Nicotine Tobacco Use Dis… Nicotine Depend… | Study design changed significantly; was submitted as a different protocol. - | |||
| NCT01272388 Details | 2018-09-12 Interventional | 4 | 1 | Tadalafil Aortic Valve St… Constriction, P… Aortic Stenosis | We designed a different pilot trial based on data obtained after this study started - the 2
studies were too overlapping to continue both. - | |||
| NCT00934661 Details | 2018-09-12 Interventional | 4 | 40 | Morphine Hip Arthroplast… | Drug was discontinued by manufacturer - | |||
| NCT03491579 Details | 2018-09-11 Interventional | 1 | 0 | Cladribine Cytarabine Recurrence AML Relapse | IMP will not be further developed - |